Sharon R Lewin
The Peter Doherty Institute for Infection and Immunity (Doherty Institute), University of Melbourne · The Doherty Institute, University of Melbourne · The Doherty Institute for Infection and Immunity, Melbourne University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sharon R Lewin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:47 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05668026 · Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ARTUniversity of Aarhus · recruiting · HIV-1-infection · principal investigator
- Ph1/Ph2NCT03198559 · Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ARTUniversity of Melbourne · terminated · HIV Infections · principal investigator
- N/ANCT02895087 · Study to Explore Natural Daily Variation and Impact of Stress in HIV LevelsUniversity of Melbourne · completed · HIV · principal investigator
- N/ANCT00637429 · HIV-HBV Co-Infection and Liver DiseaseBayside Health · unknown · HIV Infections, HIV-HBV Co-Infection · principal investigator
- N/ANCT00206531 · The Role of Naive T-Cells in HIV PathogenesisBayside Health · unknown · HIV Infections · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- The role of chemokines in the establishment of HIV latencyR56AI095073 · NIAID · MONASH UNIVERSITY · fiscal years 2012 · $271,112 awarded in 2012Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:47 UTC. The ranking covers the 200 most relevant of 29 PubMed records, and a shared surname and initials can bring in a namesake. All 29 on PubMed
- 975 citationsRCR 26.4
- Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.PLoS Pathog · 2014463 citationsRCR 13.1
- Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.Lancet HIV · 2015219 citationsRCR 7.0
- A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.Hepatology · 2008105 citationsRCR 2.9
- Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial.Nat Med · 202388 citationsRCR 7.8
- Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study.Clin Infect Dis · 202177 citationsRCR 4.0
- Broad activation of latent HIV-1 in vivo.Nat Commun · 201666 citationsRCR 2.1
- Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.J Infect Dis · 200964 citationsRCR 1.7
- Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals.Immunol Cell Biol · 201461 citationsRCR 2.0
- 50 citationsRCR 1.4